Where is Nottingham Headquarters Campus?

The European Association for Cancer Research (EACR) at its Nottingham Headquarters Campus primarily focuses on advancing cancer research through professional development, conferences, and specialized training programs rather than traditional degree courses. Key offerings include intensive workshops on cutting-edge topics such as immunotherapy, genomics, and precision oncology.

• Cancer Biology Workshops: In-depth sessions covering molecular mechanisms of carcinogenesis, tumor microenvironment, and metastasis, equipping researchers with hands-on lab techniques like CRISPR editing and single-cell sequencing.
• Clinical Trial Design Courses: Training on Phase I-III trial methodologies, regulatory compliance (e.g., EMA/FDA guidelines), biomarker development, and data analysis using R and SAS software.
• Bioinformatics and Computational Oncology: Programs teaching AI-driven drug discovery, tumor evolution modeling, and big data handling from sources like TCGA and ICGC databases.
• Grant Writing and Career Development: Seminars on securing funding from ERC, CRUK, and NIH, including mock peer-review panels and CV optimization for academic and industry roles.
• Communication Skills for Scientists: Courses on scientific writing, poster design, and public speaking, with emphasis on disseminating research at EACR congresses.

These programs attract over 1,000 participants annually from Europe and beyond, fostering collaborations via networking events. While not offering undergraduate or postgraduate degrees, the campus serves as a hub for short-term courses (1-5 days) and online modules, certified by EACR. Emphasis is placed on translational research, bridging basic science and clinical applications. Participants gain CPD credits, enhancing career progression in academia, pharma, and biotech. The curriculum evolves with scientific advances, incorporating emerging fields like liquid biopsies, CAR-T therapies, and cancer epigenetics. Interactive formats include lectures, group discussions, and practical demos in state-of-the-art facilities shared with University of Nottingham. Overall, the offerings empower early-career researchers to mid-level professionals, promoting excellence in cancer research innovation and patient outcomes.